chr16-20349012-CTTCGGGGCAGA-AGGAGGCGG
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PM4_SupportingPP2PP5_Very_Strong
The NM_003361.4(UMOD):c.278_289delTCTGCCCCGAAGinsCCGCCTCCT(p.Val93_Gly97delinsAlaAlaSerCys) variant causes a missense, disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003361.4 missense, disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.278_289delTCTGCCCCGAAGinsCCGCCTCCT | p.Val93_Gly97delinsAlaAlaSerCys | missense_variant, disruptive_inframe_deletion | 5 | NM_003361.4 | ENSP00000379442.5 | |||
UMOD | ENST00000396134.6 | c.377_388delTCTGCCCCGAAGinsCCGCCTCCT | p.Val126_Gly130delinsAlaAlaSerCys | missense_variant, disruptive_inframe_deletion | 2 | ENSP00000379438.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial juvenile hyperuricemic nephropathy type 1 Pathogenic:3Other:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0104 - Dominant negative is a known mechanism of disease in this gene and is associated with tubulointerstitial kidney disease 1 (MIM#162000) (PMID: 22117067). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0216 - In-frame insertion/deletion in a non-repetitive region that has low conservation. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - Multiple alternative amino acid changes encompassed by this inframe deletion insertion have been observed in gnomAD (v2) (highest allele count: 2 heterozygotes, 0 homozygotes). (I) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants, the calcium-binding EGF domain (DECIPHER, PMID: 30099615). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple families with UMOD-related tubulointerstitial kidney disease (ClinVar, PMIDs: 14531790, 22034507, 32274456). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional studies show that this variant causes trafficking defects and endoplasmic reticulum retention, resulting in premature intracellular polymerization (ClinVar, PMID: 22034507, 25436415). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
Common pathogenic variant; associated with less frequent gout, possible association with Later onset of ESRD -
- -
Autosomal dominant medullary cystic kidney disease with or without hyperuricemia Pathogenic:2
This patient is heterozygous for the variant, c.278_289delinsCCGCCTCCT (p.Val93_Gly97delinsAlaAlaSerCys), in the UMOD gene. This variant, located in a calcium binding EGF domain of UMOD, is likely to be pathogenic as it results in the loss of 5 residues (ValCysProGluGly), including a conserved cysteine at position 94, and the insertion of 4 residues (AlaAlaSerCys). This variant has been previously reported in several members of a family with medullary cystic kidney disease (Wolf et al 2003 Kidney Int 64:1580-1587). This variant is referred to as 383del12/ins9 in this paper. -
This complex sequence change is a deletion of 12 bp and insertion of nine bp, predicted to cause a change in the length of the protein due to an in-frame substitution of five amino acids for four amino acids in a non-repeat region of the UMOD protein, p.(Val93_Gly97delinsAlaAlaSerCys). The variant alters a cysteine residue involved in a disulphide bond in the EGF-like domain 2 (PMID: 35273390, 36038257). The estimated population minor allele frequency in the population database gnomAD v4.1 for this complex variant is 0.001% (13/1,165,668 alleles) in the European (non-Finnish) population. It has been reported as a British founder variant for hereditary nephropathy and segregates with renal disease in multiple families (PMID: 36038257). The variant demonstrates deficient intracellular trafficking associated with endoplasmic reticulum retention and reduced secretion in multiple in vitro functional assays with limited validation (PMID: 22034507, 32954071). Based on the classification scheme RMH Modified ACMG Guidelines v1.7.0, this variant is classified as PATHOGENIC. Following criteria are met: PS4, PP1_Strong, PM1, PM2_Supporting, PS3_Supporting. -
not provided Pathogenic:2
PP1_strong, PM2_supporting, PM4, PS3, PS4_moderate -
Identified in multiple unrelated families with UMOD-associated kidney disease (Smith et al., 2011; Wolf et al., 2003; Chun et al. 2020); reported in Wolf et al. as c.383del12/ins9 due to use of alternate nomenclature; In-frame deletion of 5 amino acids and insertion of 4 different amino acids in a non-repeat region predicted to critically alter the protein; Published functional studies in HEK293 cells demonstrate that c.278_289del12ins effects protein maturation and results in ER retention (Smith et al., 2011), and functional studies in tsA 201 cells demonstrate that c.278_289del12ins results in intracellular protein aggregation and premature polymerization (Stewart et al., 2015); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25436415, 22034507, 14531790, 32274456, 32939031, 20301530) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at